Literature DB >> 15579499

Calcineurin Abeta is central to the expression of the renal type II Na/Pi co-transporter gene and to the regulation of renal phosphate transport.

Yulia Moz1, Ronen Levi, Vardit Lavi-Moshayoff, Keith B Cox, Jeffery D Molkentin, Justin Silver, Tally Naveh-Many.   

Abstract

The sensing and response to extracellular phosphate (Pi) concentration is preserved from prokaryotes to mammals and ensures an adequate supply of Pi in the face of large differences in its availability. In mammals, the kidneys are central to Pi homeostasis. Renal Pi reabsorption is mediated by a Na/Pi co-transporter that is regulated by a renal Pi sensing system and humoral factors. The signal transduction by which Pi regulates type II Na/Pi activity is largely unknown. It is shown that calcineurin inhibitors specifically and dramatically decrease type II Na/Pi gene expression in a proximal tubule cell line and in vivo. Mice with genetic deletion of the calcineurin Abeta gene had a marked decrease in type II Na/Pi mRNA levels and remarkably did not show the expected increase in type II Na/Pi mRNA levels after the challenge of a low-Pi diet. In contrast, the regulation of renal 25(OH)-vitamin D 1alpha-hydroxylase gene expression by Pi was intact. This is the first demonstration that calcineurin has a crucial role in the signal transduction pathway regulating renal Pi homeostasis both in vitro and in vivo. These results suggest that the use of calcineurin inhibitors contributes to the renal Pi wasting seen in renal transplant patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579499     DOI: 10.1097/01.ASN.0000144207.44469.BE

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

Review 1.  FGF23 and PTH--double agents at the heart of CKD.

Authors:  Justin Silver; Mariano Rodriguez; Eduardo Slatopolsky
Journal:  Nephrol Dial Transplant       Date:  2012-03-23       Impact factor: 5.992

2.  Association of pretransplant serum phosphorus with posttransplant outcomes.

Authors:  Marcelo S Sampaio; Miklos Z Molnar; Csaba P Kovesdy; Rajnish Mehrotra; Istvan Mucsi; John J Sim; Mahesh Krishnan; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

3.  Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.

Authors:  Pieter Evenepoel; Bjorn K I Meijers; Hylke de Jonge; Maarten Naesens; Bert Bammens; Kathleen Claes; Dirk Kuypers; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

4.  The Role of Methionine Oxidation/Reduction in the Regulation of Immune Response.

Authors:  Abdulbaki Agbas; Jackob Moskovitz
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

Review 5.  Phosphate and FGF-23 homeostasis after kidney transplantation.

Authors:  Leandro C Baia; Ita Pfeferman Heilberg; Gerjan Navis; Martin H de Borst
Journal:  Nat Rev Nephrol       Date:  2015-09-29       Impact factor: 28.314

Review 6.  Electrolyte and Acid-base disturbances induced by clacineurin inhibitors.

Authors:  Chang Hwa Lee; Gheun-Ho Kim
Journal:  Electrolyte Blood Press       Date:  2007-12-31

7.  Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransporters.

Authors:  Maria Haller; Stefan Amatschek; Julia Wilflingseder; Alexander Kainz; Bernd Bielesz; Ivana Pavik; Andreas Serra; Nilufar Mohebbi; Jürg Biber; Carsten A Wagner; Rainer Oberbauer
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.